• Fingolimod (FTY720) in Immune Engineering

  2026-09-01

  Fingolimod (FTY720) gives researchers a controllable way to study S1P-dependent lymphocyte trafficking, CNS signaling, and treatment-relevant immune suppression. Used alongside—but not assumed to improve—magnetically guided CAR-T-mimicking platforms, it can help separate cell distribution effects from tumor-cell killing and neurotrophic responses.

• Exercise, Muscle EVs, and Microglial Aβ Clearance

  2026-08-31

  A 2026 Nature Aging study identifies skeletal muscle-derived extracellular vesicles (SKM-EVs) as a mechanistic link between swimming exercise and improved cognition in Alzheimer’s disease mice. The work connects EV-carried miR-378a-3p with p110α-dependent lipid regulation in disease-associated microglia, providing a testable exercise-mimicking strategy for enhancing amyloid-β plaque clearance.

• CCK8 Workflow for Cell Viability and Cancer Research

  2026-08-31

  Build a practical cck8 workflow for measuring proliferation, viability, and drug response without a formazan solubilization step. Learn how to use Cell Counting Kit-8 data alongside clonogenic, migration, and molecular assays to interrogate PCGF1-driven colon cancer phenotypes.

• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-08-30

  The reference study identifies a receptor-specific effect in which several naturally occurring angiotensin peptides enhance SARS-CoV-2 spike binding, with angiotensin IV showing the strongest activity among the tested peptides. Its peptide-deletion and tyrosine-modification experiments connect renin-angiotensin system biology with viral receptor engagement while also emphasizing that biochemical binding results do not yet establish increased infection in vivo.

• G-1: Selective GPR30 Agonist Workflows

  2026-08-29

  G-1 provides a practical way to isolate rapid GPR30 signaling from classical estrogen-receptor effects in immune, cancer, and cardiovascular assays. This guide translates reference-study findings into reproducible workflows, dosing logic, controls, and troubleshooting steps.

• Gallein: A Strategic Lens on GPCR Translation

  2026-08-29

  Gallein offers translational researchers a way to interrogate G protein βγ-dependent signaling across cancer, immunology, cardiac inflammation, and emerging metabolic biology. By connecting recent findings on the lactate–GPR81–FARP1 axis with preclinical evidence for Gβγ modulation, this article outlines how to use Gallein as a mechanistic probe while avoiding overinterpretation across disease models.

• Azilsartan: A Translational AT1R Research Strategy

  2026-08-28

  Azilsartan (TAK-536) offers a precise pharmacological way to interrogate AT1 receptor signaling across cardiovascular and neuroinflammatory models. This thought-leadership guide connects its established renin-angiotensin system biology with evidence from reactive astrocyte–microglia research, while outlining validation strategies, model limitations, and translational priorities.

• LDH Cytotoxicity Assay Kit: Practical Workflow

  2026-08-28

  The LDH Cytotoxicity Assay Kit, SKU K2228, provides a non-radioactive method for cell cytotoxicity measurement by quantifying LDH released into culture medium after membrane damage. It is useful for comparative cell damage quantification, but should not be used alone to identify apoptosis mechanisms or replace interference controls and orthogonal validation.

• Caspofungin Workflows for Resistant Candida Research

  2026-08-27

  Caspofungin gives researchers a direct way to interrogate fungal cell wall biosynthesis and benchmark activity against difficult Candida phenotypes. This workflow-focused guide connects susceptibility testing, delayed-treatment models, assay troubleshooting, and comparative interpretation with ibrexafungerp.

• DMH1 for ALK2-Controlled Organoid Assays

  2026-08-27

  DMH1 provides a selective way to test how ALK2-dependent BMP signaling shapes organoid self-renewal, differentiation, and disease phenotypes. This practical guide connects pathway validation with non-small cell lung cancer research, including migration, proliferation, and mechanistic readouts.

• hiPSC Intestinal Organoids for Pharmacokinetics

  2026-08-26

  Saito and colleagues developed a direct three-dimensional culture approach for generating expandable intestinal organoids from human induced pluripotent stem cells. The organoids could be maintained, cryopreserved, and converted into intestinal epithelial monolayers with enterocyte-associated cytochrome P450 and transporter activities, creating a more human-relevant platform for pharmacokinetic studies.

• Live-Dead Cell Staining Kit for 3D Tumor Models

  2026-08-26

  Use Calcein-AM and Propidium Iodide dual fluorescence to distinguish viable and membrane-compromised cells in 2D cultures, flow cytometry, and dense 3D tumor constructs. The workflow is especially useful for validating hypoxic, drug-resistant glioblastoma models without confusing reduced metabolic activity with confirmed cell death.

• Tropifexor (LJN452) for FXR Barrier Research

  2026-08-25

  Tropifexor (LJN452) enables low-nanomolar FXR activation studies across intestinal organoids, epithelial barrier assays, and metabolic disease models. This practical guide translates neonatal parenteral nutrition research into controlled workflows, assay choices, and troubleshooting strategies.

• CD28–ARS2 Control of CD8+ T-Cell Metabolism

  2026-08-25

  This study identifies a CD28–ARS2 signaling axis that reshapes alternative splicing of PKM and enables metabolically flexible CD8+ T-cell responses. Its findings connect costimulatory signaling to PKM2-dependent glucose utilization, interferon-gamma production, and antitumor activity while separating this mechanism from canonical PI3K signaling.

• HOXC8, Caspase-1, and Pyroptosis in Lung Cancer

  2026-08-24

  The reference study identifies HOXC8 as a transcriptional suppressor of CASP1 that protects non-small cell lung cancer cells from ASC-independent pyroptosis. Its experiments connect HOXC8–HDAC1/2 promoter regulation with caspase-1 abundance, GSDMD pore formation, and tumor growth, suggesting a mechanism by which a developmental transcription factor can support lung tumorigenesis.

450 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page